Pillar Pacific Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Pillar Pacific Capital Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$48K	–	301
2020 Q2	$48K	Hold	10,000	–	–	0.01%	290
2020 Q1	$20K	Hold	10,000	–	–	﹤0.01%	270
2019 Q4	$35K	Hold	10,000	–	–	﹤0.01%	292
2019 Q3	$29K	Hold	10,000	–	–	﹤0.01%	286
2019 Q2	$38K	Hold	10,000	–	–	﹤0.01%	296
2019 Q1	$81K	Hold	10,000	–	–	0.01%	291
2018 Q4	$81K	Sell	10,000 -800	-7%	-$6.22K	0.01%	277
2018 Q3	$82K	Hold	10,800	–	–	0.01%	304
2018 Q2	$62K	Hold	10,800	–	–	0.01%	300
2018 Q1	$52K	Sell	10,800 -850	-7%	-$4.37K	0.01%	290
2017 Q4	$57K	Sell	11,650 -350	-3%	-$1.7K	0.01%	291
2017 Q3	$62K	Hold	12,000	–	–	0.01%	292
2017 Q2	$67K	Hold	12,000	–	–	0.01%	296
2017 Q1	$101K	Sell	12,000 -7,000	-37%	-$48.7K	0.01%	295
2016 Q4	$120K	Hold	19,000	–	–	0.02%	296
2016 Q3	$84K	Hold	19,000	–	–	0.01%	298
2016 Q2	$54K	Hold	19,000	–	–	0.01%	297
2016 Q1	$53K	Hold	19,000	–	–	0.01%	293
2015 Q4	$196K	Hold	19,000	–	–	0.04%	274
2015 Q3	$217K	Hold	19,000	–	–	0.04%	256
2015 Q2	$283K	Buy	+19,000	New	+$216K	0.05%	223

Other funds holding BCRX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pillar Pacific Capital Management's BCRX Position: Q3 2020 in Review

Pillar Pacific Capital Management sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2020, closing a stake of 10,000 shares — an estimated $48K sold.

Pillar Pacific Capital Management first reported a position in BCRX in Q2 2015 and held it in 21 quarters. The position peaked at $283K in Q2 2015. 154 funds tracked by Wall St. Rank hold BCRX as of Q3 2020.

Pillar Pacific Capital Management reported no remaining BioCryst Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Pillar Pacific Capital Management sold 10,000 BioCryst Pharmaceuticals shares in Q3 2020, an estimated $48K.
Pillar Pacific Capital Management first reported a position in BioCryst Pharmaceuticals in Q2 2015 and held it in 21 quarters.
Pillar Pacific Capital Management's BioCryst Pharmaceuticals position peaked at $283K in Q2 2015.
154 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2020.

Based on Pillar Pacific Capital Management's 13F filing for Q3 2020, filed 3 Nov 2020.